Literature DB >> 15520445

Tadalafil in primary pulmonary arterial hypertension.

Emiliano Antonio Palmieri, Flora Affuso, Serafino Fazio, Danilo Lembo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15520445     DOI： 10.7326/0003-4819-141-9-200411020-00033

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  10 in total

Review 1.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

Review 2.  Pulmonary hypertension-"state of the art" management in 2012.

Authors:  Anita Saxena
Journal:  Indian Heart J       Date:  2012-03-26

3.  Non-congenital heart disease associated pediatric pulmonary arterial hypertension.

Authors:  D D Ivy; J A Feinstein; T Humpl; E B Rosenzweig
Journal:  Prog Pediatr Cardiol       Date:  2009-12-01

Review 4.  Drug treatment of pulmonary arterial hypertension: current and future agents.

Authors:  Marius M Hoeper
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Tadalafil: the evidence for its clinical potential in the treatment of pulmonary arterial hypertension.

Authors:  Stuart D Katz
Journal:  Core Evid       Date:  2008-07-31

Review 6.  The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension.

Authors:  Jeremy A Falk; Kiran J Philip; Ernst R Schwarz
Journal:  Vasc Health Risk Manag       Date:  2010-05-06

Review 7.  Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.

Authors:  Emily J Tsai; David A Kass
Journal:  Pharmacol Ther       Date:  2009-03-21       Impact factor: 12.310

8.  Use of tadalafil for treating pulmonary arterial hypertension secondary to chronic obstructive pulmonary disease.

Authors:  Hyun-Sook Kim; Jae-Hyeong Park; Seoung Ju Park; Jong Kwan Park; Heung-Bum Lee
Journal:  Korean J Intern Med       Date:  2007-03       Impact factor: 2.884

Review 9.  The limits of oral therapy in pulmonary arterial hypertension management.

Authors:  Qian-Qian Liu; Zhi-Cheng Jing
Journal:  Ther Clin Risk Manag       Date:  2015-11-23       Impact factor: 2.423

Review 10.  Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based review.

Authors:  Adam M Henrie; James J Nawarskas; Joe R Anderson
Journal:  Core Evid       Date:  2015-11-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.